SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucell (ICCC) - Potential Treatment for Cryptosporidium
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve who wrote (1)12/18/1996 9:32:00 AM
From: Jonathan Rothschild   of 46
 
I've accumulated a large position in this stock. While there may be no movement through the end of 96, this is the most undervalued biotech stock in the whole sector. No one knows about it. Paramount Capital, a very sophisticated biotech boutique house owns about 8%. They have 4 MM in revenues to fund their R & D and balance environmental projects with clinical trials. They have some corporate partners already and may have another deal early next year. New milk antibody products on line for March or April. Recently received a 100 M SBO grant. There are only 2.3 MM shares outstanding with no preferred or messy warrants. There appears to be a founder selling who no longer has anything to do with the company. This has been hurting the stock for the last six months. Once he steps out of the way and year end tax selling ends, watch out. There's no size out there.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News